info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
in IN: +91-826-083-6500
Home » Medical Devices »

Hormone Replacement Therapy Market By Therapy Type (Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy, Progestogen Hormone Replacement Therapy), Route Of Administration (Oral, Parenteral, Others) By Geography, Segment revenue estimations, Forecast: 2021-2028

Published On: Jan-2022   |   Base Year: 2000   |   No Of Pages: 140   |   Historical Data: 2015 - 2019   |   Formats: PDF   |   Report ID: 67307763

In 2020, the valuation of the Global Hormone Replacement Therapy Marketwas $ 23.156billion. It is predicted to reach $ 39.631 billion by 2028, representing a CAGR of 7.839 percent throughout the period of 2020-2028. 

 

Hormone replacement therapy (HRT) is a treatment procedure for replacing and replenishing hormones in the human body that are at inadequate levels compared to those required for normal physiology. The most well-known application of HRT is in the treatment of menopause symptoms. In other words, Hormone replacement therapy is a medical treatment procedure in which patients are given hormones to replace naturally occurring hormones or to augment naturally occurring hormones that are missing. In the case of females, this treatment is used to restore the hormone levels in women whoare at the stage of menopause, allowing the body to operate normally.

Hormone replacement therapy (HRT) is the use of hormones to replace natural hormones when the body's production is insufficient. For instance, hormone replacement therapy is usually given to thyroid patients and human growth hormone patients. Furthermore, HRT was often administered to menopausal women for the alleviation of indications such as night sweats, hot flushes, sleep disturbances, psychological and genito-urinary disorders (urinary frequency and vaginal dryness), as well as the prevention of osteoporosis. In addition, a survey of 2,000 American women aged 30 to 60 indicated that approximately 47% of the surveyed population experienced the symptoms of hormonal imbalance in 2019.

Menopause is the most frequently reported consequence of age-related hormonal changes.It often begins around the age of 50 in women around the world. By the age of 50, the levels of oestrogen and progesterone produced by women significantly decreases. The pituitary gland compensates for the decline in oestrogen and progesterone production by increasing the output of follicle-stimulating hormone.

 

Market Drivers

  • The rise in prevalence of menopausal illness and increased awareness of post-menopausal difficulties among women are two significant factors driving the worldwide HRT market.
  • The hormone replacement therapy market trendis being driven by a large increase in the incidence rate of hormonal abnormalities in newborns, adults, and the elderly. Moreover, disease like The Prader-Willi syndrome (PWS) affects one out of every 15,000 babies.
  • Low-Dosevaginal estrogen therapy, topical estrogen therapy,hysterectomy with bilateral salpingooophorectomy, Systemic hormone therapy, Bioidentical hormone replacement therapyare all the factors that driving the market globally.

 

Market Restraint

  • During the projected period, unfavourable effects of hormone replacement therapy are expected to restrain market expansion.
  • The high expense of hormone replacement therapy, as well as the risk of acquiring cancer from HRTs, are expected to stifle global market growth.
  • Risks involved in the hormone replacement therapy includes Heart disease, Stroke, Blood clots, Breast cancer which are expected to restrain the market.

 

Market Opportunity

  • The needforbioidentical hormone replacement therapy and the use of telemedicine for hormone replacement therapy, are projected to give a lucrative opportunity for the worldwide hormone replacement therapy market to expand in the near future.

 

Market Segmentation

The market segments that are covered in thehormone replacement therapy market report are as follows:

By Route Of Administration

  • Oral
  • Parenteral
  • Others

 

By Therapy Type

  • Estrogen Hormone Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Hormone Replacement Therapy
  • Testosterone Hormone Replacement Therapy
  • Progestogen Hormone Replacement Therapy

 

By Indication

  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others

 

By Region

North America

  • U.S.
  • Canada
  • Mexico

 

Europe

  • Germany
  • France
  • Italy
  • Switzerland
  • UK
  • Rest of Europe

 

Asia-Pacific

  • Japan
  • China
  • India
  • Rest of Asia-Pacific

LAMEA

  • Brazil
  • Israel
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

 

Based on Route Of Administration, the oral market segment accounted for the largest proportion of the hormone replacement treatment market in 2020 and is predicted to increase at the quickest rate over the forecast period. This is due to the fact that oral administration of testosterone medications is highly favoured, and oral medicationis the most prevalent form of oestrogen replacement therapy.

In terms of therapy type, estrogen hormone replacement therapy was the market leader in 2020. This is due to women's increased usage of estradiol products to help them maintain hormonal balance after menopause or hysterectomy. Dryness, burning, itching, and pain during intercourse are some of the vaginal symptoms of menopause that can be alleviated by oestrogen replacement hormone therapy. Estrogen can be taken as aEstrogenpill, gel, Estrogen patch, lotion, or a spray. It has a good success rate in the treatment of menopausal night sweats and hot flashes. Around 45 percent of women aged 40 to 60 reported seeking medical advice on the benefits and drawbacks of utilising hormone replacement therapy (HRT) after menopause.

Menopause is predicted to expand at the quickest rate in terms of indication from 2021 to 2028, as there is a great advancement in the number of postmenopausal women and the expansion of the menopausal window from 40 to 55 years. In accordance to American Congress of Obstetricians and Gynecologists, around 6,000 women reachmenopause every day.

According to World Health Organisation (WHO), around 15 million neonates are born prematurely, with approximately 85% of these children being underdeveloped. Hormone treatment is used in adults to treat disorders like short bowel syndrome and pituitary tumours.

 

The North American market dominated the global hormone replacement therapy market in 2019, due to the rise in manufacturer’s release of various generic hormone replacement therapy medicines, an increase in target population, and advances in drug delivery technologies, as well as the creation of new formulations. Also, because of the rising public awareness, the hormone replacement treatment market in Asia Pacific is expected to growquickly in the future years. Emerging countries such as Japan, India, and China will play a significant role in market expansion.

In accordance to the NIH(National Institutes of Health), half of postmenopausal women have used HRT at least once.

In 2014, more than 2.5 million Americans received testosterone treatment, according to the American Academy of Family Physicians.

 

In accordance toNIH, about half of all postmenopausal women in the United States had hormone replacement therapy (HRT) at some point in their life. In addition, roughly 1.3 million American women will enter the menopause phase each year by 2021, according to a study published in Statpearls.

According to studies conducted by organisations such as Rose Research, the North American Menopause Society (NAMS), and Therapeutic MD, approximately one million women in the United States are currently using hormone replacement therapy, with the number expected to rise to 2.5 million in the near future.

According to a study published in the Journal of Menopausal Medicine in 2020, about 75 percent of women experience menopause symptoms between the ages of 45 and 55, resulting in a decrease in self-esteem.

According to the World Population Ageing 2019 study, women will account for 54 percent of the global population aged 65 and over by 2050, with a life expectancy at birth of 74.7 years in 2019.

According to the American Thyroid Association (ATA), more than 12% of the US population is expected to have a thyroid issue during their lifetime, and nearly 20 million Americans are impacted by thyroid illness each year. As a result of the significant prevalence of thyroid hormone imbalance among the people in the United States, the studied market in the region is predicted to grow.

 

Competitive Analysis

Key Market Players in the market are as follows :

  • Abbott Laboratories
  • Bayer Ag.
  • Eli Lily And Company
  • Hoffmann-La Roche Ltd. (Genentech, Inc.)
  • Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
  • Merck Kgaa
  • Mylan N.V. (Viatris Inc.)
  • Novartis International Ag
  • Novo Nordisk A/S
  • Pfizer Inc.

 

Recent Developments

  • In December 2020, The US FDA approved Myovant Sciences' Orgovyx (relugolix). Orgovyx (relugolix) is an orally administered treatment that works by preventing the pituitary gland from producing luteinizing hormone and follicle-stimulating hormone, resulting in a decrease in the amount of testosterone produced by the testicles. This aids in the treatment of advanced prostate cancer in adults.
  • In August 2020, Bayer AG announced the acquisition of KanDy Therapeutics Inc., which will help Bayer to expand its women's medicine pipeline by includingKanDy's menopausal treatment in its portfolio.
  • In August 2020, the FDA (US Food and Drug Administration) authorised Sogroya (somapacitan), a human growth hormone (HGH) therapy for adults with growth hormone insufficiency that is administered once a week via injection under the skin. As a result, the region's analysed market is projected to be driven by the high trend of product approvals.

 

The key products that are developed by the market leaders

Name of the product

Function

Key Players

THYROCAB

It is used in curing hyperthyroidism

Abbott Laboratories

 

ANGELIQ

It is used to reduce menopause symptoms

Bayer Inc.

Adakveo

It is used to reduce the frequency of vasoocclusive crises (VOCs) in adults and pediatric patients

Novartis International Ag

 

Frequently Asked Question About This Report

N/A

1.   Introduction

       1.1.  Study Objective

       1.2.  Market Definition        

       1.3.  Study Scope

              1.3.1. Markets Covered

              1.3.2. Geographic Scope

              1.3.3. Years Considered

              1.3.4. Stakeholders

2.   Research Methodology

       2.1.  Data Procurement

       2.2.  Paid Database

              2.2.1. Secondary Data

                     2.2.1.1. Key Secondary sources

              2.2.2. Primary Data

                     2.2.2.1 Primary sources

                     2.2.2.2. Key industry insights

                     2.2.2.3. Primary interviews with experts

                     2.2.2.4. Key primary respondent list

       2.3.  Market Size Estimation

       2.4.  Bottom-Up and Top-Down Approaches

              2.4.1.       Bottom-Up Approach

                     2.4.1.1.            Approach for arriving at market size by bottom-up analysis

              2.4.2.       Top-Down Approach

                     2.4.2.1.            Approach for Capturing Market Size by Top-Down Analysis

       2.5.  Market Breakdown and Data Triangulation

       2.6.  Research Methodology

       2.7.  Risk Assessment

3.  Executive Summary

       3.1   Hormone Replacement Therapy Market: Post-Covid-19

              3.1.1        Actual Scenario

              3.1.2        Pessimistic Scenario

              3.1.3        Optimistic Scenario

              3.1.4        Market Summary

4. Industry Outlook

       4.1   Market Snapshot

       4.2   Global Hormone Replacement Therapy Market

              4.2.1        Global Hormone Replacement Therapy market, 2020 – 2028 (USD Million)

       4.3   Regional Business Analysis

              4.3.1        Global Hormone Replacement Therapy market, by region, 2020 - 2028 (USD Million)

       4.4   By Therapy Type Business Analysis

              4.4.1        Global Hormone Replacement Therapy market, By Therapy Type, 2020 - 2028 (USD Million)

       4.5   By Indication Business Analysis

              4.5.1        Global Hormone Replacement Therapy market, By Indication, 2020 - 2028 (USD Million)

       4.6   Route Of Administration Business Analysis

              4.6.1        Global Hormone Replacement Therapy market, By Route Of Administration, 2020 - 2028 (USD Million)

       4.7   Value Chain Analysis

       4.8   Market Variable Analysis

              4.8.1        Market Drivers Analysis

              4.8.2        Market Restraints Analysis

       4.9 Business Environment Analysis Tool

              4.9.1        Hormone Replacement Therapy market PEST analysis

              4.9.2        Hormone Replacement Therapy market Porter’s analysis

       4.10 Penetration & Growth Prospect Mapping

5. Market Dynamics

       5.1.  Introduction

       5.2.  Market Dynamics

              5.2.1.       Drivers

              5.2.2.       Restraints

              5.2.3.       Opportunities

              5.2.4.       Challenges

       5.3.  Impact of Covid-19 On Hormone Replacement Therapy Market

       5.4.  Value Chain Analysis

       5.5.  Ecosystem

       5.6.  Patent Analysis

       5.7.  Trade Analysis

       5.8.  Tariff Analysis

       5.9.  Case Study Analysis

5.10.      Porter’s Five Forces Analysis

              5.10.1      Threat of New Entrants

              5.10.2      Threat of Substitutes

              5.10.3      Bargaining Power of Buyers

              5.10.4      Bargaining Power of Suppliers

              5.10.5      Degree of Competition

       5.11.               Route Of Administration Analysis

              5.11.1.     Trends in Route Of Administration (2014-2020)

              5.11.2.     Trends in Route Of Administration (2021-2028)

       5.12.               Pricing Analysis

              5.12.1.     Average Price Trend Analysis (By region, By Countries)

6. Competitive & Vendor Landscape

       6.1.  Company Market Share Analysis

       6.2.  Manufacturers Hormone Replacement Therapy Manufacturing Sites, Area Served, Product Therapy Type

       6.3.  Hormone Replacement Therapy Market Competitive Situation and Trends

       6.4.  Manufacturers Mergers & Acquisitions, Expansion Plans

7. Global Hormone Replacement Therapy Market: By Therapy Type Segment Analysis

       7.1.  Introduction

       7.2.  Sales Volume & Revenue Analysis (2020-2028)

       7.3.  Estrogen Hormone Replacement Therapy

              7.3.1. Estrogen Hormone Replacement Therapy market, 2020 - 2028 (USD Million)

       7.4.  Human Growth Hormone Replacement Therapy

              7.4.1. Human Growth Hormone Replacement Therapy market, 2020 - 2028 (USD Million)

       7.5.  Thyroid Hormone Replacement Therapy

              7.5.1. Thyroid Hormone Replacement Therapy market, 2020 - 2028 (USD Million)

       7.6.  Testosterone Hormone Replacement Therapy

              7.6.1. Testosterone Hormone Replacement Therapy market, 2020 - 2028 (USD Million)

       7.7.  Progestogen Hormone Replacement Therapy

              7.7.1. Progestogen Hormone Replacement Therapy market, 2020 - 2028 (USD Million)

8. Global Hormone Replacement Therapy Market: By Indication Segment Analysis

       8.1.  Introduction

       8.2.  Sales Volume & Revenue Analysis (2020-2028)

       8.3.  Menopause

              8.3.1.       Menopause market, 2020 - 2028 (USD Million)

       8.4.  Hypothyroidism

              8.4.1.       Hypothyroidism market, 2020 - 2028 (USD Million)

       8.5.  Male Hypogonadism

              8.5.1.       Male Hypogonadism market, 2020 - 2028 (USD Million)

       8.6. Growth Hormone Deficiency

              8.6.1.       Growth Hormone Deficiency market, 2020 - 2028 (USD Million)

       8.7.  Others

              8.7.1.       Others market, 2020 - 2028 (USD Million)

9. Global Hormone Replacement Therapy Market: By Route Of Administration Segment Analysis

       9.1.  Introduction

       9.2.  Sales Volume & Revenue Analysis (2020-2028)

       9.3.  Oral

              9.3.1.       Oral market, 2020 - 2028 (USD Million)

       9.4.  Parenteral

              9.4.1.       Parenteral market, 2020 - 2028 (USD Million)

       9.5.  Others

              9.5.1.       Others market, 2020 - 2028 (USD Million)

10. Global Hormone Replacement Therapy Market: Regional Outlook

       10.1 North America

              10.1.1.     North America  Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

              10.1.2.     North America  Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

              10.1.3.     North America  Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

              10.1.4.     North America  Hormone Replacement Therapy market, by Country, 2020 - 2028 (USD Million)

       10.1.4.1. U.S.

                     10.1.4.1.1.      U.S. Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

                     10.1.4.1.2.      U.S. Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

                     10.1.4.1.3.      U.S. Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

     10.1.4.2.  Canada

                     10.1.4.2.1.      Canada Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

                     10.1.4.2.2.      Canada Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

                     10.1.4.2.3.      Canada Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

10.2. Europe

              10.2.1.     Europe Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

              10.2.2.     Europe Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

              10.2.3.     Europe Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

              10.2.4.     Europe Hormone Replacement Therapy market, by country, 2020 - 2028 (USD Million)

    10.2.4.1    U.K.

                     10.2.4.1.1.      U.K. Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

                     10.2.4.1.2.      U.K. Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

                     10.2.4.1.3.      U.K. Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

   10.2.4.2.            Germany

                     10.2.4.2.1.      Germany Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

                     10.2.4.2.2.      Germany Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

                     10.2.4.2.3.      Germany Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

   10.2.4.3.            France

                     10.2.4.3.1.      France Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

                     10.2.4.3.2.      France Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

                     10.2.4.3.3.      France Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

    10.2.4.4.           Rest of Europe

                     10.2.4.4.1.      Rest of Europe Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

                     10.2.4.4.2.      Rest of Europe Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

                     10.2.4.4.3.      Rest of Europe Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

       10.3.               Asia Pacific

              10.3.1.     Asia Pacific Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

              10.3.2.     Asia Pacific Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

              10.3.3.     Asia Pacific Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

              10.3.4.     Asia Pacific Hormone Replacement Therapy market, by country, 2020 - 2028 (USD Million)

   10.3.4.1.            China

                     10.3.4.1.1.      China Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

                     10.3.4.1.2.      China Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

                     10.3.4.1.3.      China Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

   10.3.4.2.            India

                     10.3.4.2.1.      India Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

                     10.3.4.2.2.      India Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

                     10.3.4.2.3.      India  Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

   10.3.4.3.            Japan

                     10.3.4.3.1.      Japan Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

                     10.3.4.3.2.      Japan Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

                     10.3.4.3.3.      Japan Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

   10.3.4.4.            South Korea

                     10.3.4.4.1.      South Korea Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

                     10.3.4.4.2.      South Korea Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

                     10.3.4.4.3.      South Korea Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

10.3.4.5.               Rest of ASIA PACIFIC

                     10.3.4.5.1.      Rest of ASIA PACIFIC Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

                     10.3.4.5.2.      Rest of ASIA PACIFIC Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

                     10.3.4.5.3.      Rest of ASIA PACIFIC Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

       10.4.               Latin America

              10.4.1.     Latin America Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

              10.4.2.     Latin America Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

              10.4.3.     Latin America Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

              10.4.4.     Latin America Hormone Replacement Therapy market, by country, 2020 - 2028 (USD Million)

10.4.4.1.               Brazil

                     10.4.4.1.1.      Brazil Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

                     10.4.4.1.2.      Brazil Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

                     10.4.4.1.3.      Brazil Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

10.4.4.2.               Mexico

                     10.4.4.2.1.      Mexico Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

                     10.4.4.2.2.      Mexico Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

                     10.4.4.2.3.      Mexico Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

                     10.4.4.3.          Rest of the Latin America

                     10.4.4.3.1.      Rest of the Latin America Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

                     10.4.4.3.2.      Rest of the Latin America Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

                     10.4.4.3.3.      Rest of the Latin America Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

       10.5.               MEA

              10.5.1.     MEA Hormone Replacement Therapy market, by By Therapy Type, 2020 - 2028 (USD Million)

              10.5.2.     MEA Hormone Replacement Therapy market, by By Indication, 2020 - 2028 (USD Million)

              10.5.3.     MEA Hormone Replacement Therapy market, by Route Of Administration, 2020 - 2028 (USD Million)

              10.5.4.     MEA Hormone Replacement Therapy market, by Region, 2020 - 2028 (USD Million)

 

11. Competitive Landscape

       11.1 Abbott Laboratories

              11.1.1.     Company overview

              11.1.2.     Financial performance

              11.1.3.     Product Portfolio Analysis

              11.1.4.     Business Strategy & Recent Development

       11.2. Bayer Ag

              11.2.1.     Company overview

              11.2.2.     Financial performance

              11.2.3.     Product Portfolio Analysis

              11.2.4.     Business Strategy & Recent Development

       11.3. Eli Lily And Company

              11.3.1.     Company overview

              11.3.2.     Financial performance

              11.3.3.     Product Portfolio Analysis

              11.3.4.     Business Strategy & Recent Development

       11.4. Hoffmann-La Roche Ltd. (Genentech, Inc.)

              11.4.1.     Company overview

              11.4.2.     Financial performance

              11.4.3.     Product Portfolio Analysis

              11.4.4.     Business Strategy & Recent Development

       11.5. Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)

              11.5.1.     Company overview

              11.5.2.     Financial performance

              11.5.3.     Product Portfolio Analysis

              11.5.4.     Business Strategy & Recent Development

       11.6. Merck Kgaa

              11.6.1.     Company overview

              11.6.2.     Financial performance

              11.6.3.     Product Portfolio Analysis

              11.6.4.     Business Strategy & Recent Development

       11.7. Mylan N.V. (Viatris Inc.)

              11.7.1.     Company overview

              11.7.2.     Financial performance

              11.7.3.     Product Portfolio Analysis

              11.7.4.     Business Strategy & Recent Development

       11.8. Novartis International Ag

              11.8.1.     Company overview

              11.8.2.     Financial performance

              11.8.3.     Product Portfolio Analysis

              11.8.4.     Business Strategy & Recent Development

       11.9. Novo Nordisk A/S

              11.9.1.     Company overview

              11.9.2.     Financial performance

              11.9.3.     Product Portfolio Analysis

              11.9.4.     Business Strategy & Recent Development

       11.10. Pfizer Inc.

              11.10.1.  Company overview

              11.10.2.  Financial performance

              11.10.3.  Product Portfolio Analysis

              11.10.4.  Business Strategy & Recent Development

 

List of Tables (53 Tables)

TABLE 1.  Hormone Replacement Therapy MARKET, By Therapy Type, 2020-2028 (USD Million)

TABLE 2.  Hormone Replacement Therapy MARKET FOR Estrogen Hormone Replacement Therapy, BY REGION, 2020-2028 (USD Million)

TABLE 3.  Hormone Replacement Therapy MARKET FOR Human Growth Hormone Replacement Therapy, BY REGION, 2020-2028 (USD Million)

TABLE 4.  Hormone Replacement Therapy MARKET FOR Thyroid Hormone Replacement Therapy, BY REGION, 2020-2028 (USD Million)

TABLE 5.  Hormone Replacement Therapy MARKET FOR Testosterone Hormone Replacement Therapy, BY REGION, 2020-2028 (USD Million)

TABLE 6.  Hormone Replacement Therapy MARKET FOR Progestogen Hormone Replacement Therapy, BY REGION, 2020-2028 (USD Million)

TABLE 7. Hormone Replacement Therapy MARKET, By Indication, 2020-2028 (USD Million)

TABLE 8. Hormone Replacement Therapy MARKET FOR Menopause, BY REGION, 2020-2028 (USD Million)

TABLE 9. Hormone Replacement Therapy MARKET FOR Hypothyroidism, BY REGION, 2020-2028 (USD Million)

TABLE 10. Hormone Replacement Therapy MARKET FOR Male Hypogonadism, BY REGION, 2020-2028 (USD Million)

TABLE 11. Hormone Replacement Therapy MARKET FOR Growth Hormone Deficiency, BY REGION, 2020-2028 (USD Million)

TABLE 12. Hormone Replacement Therapy MARKET FOR Others, BY REGION, 2020-2028 (USD Million)

TABLE 13. Hormone Replacement Therapy MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 (USD Million)

TABLE 14. Hormone Replacement Therapy MARKET FOR Oral, BY REGION, 2020-2028 (USD Million)

TABLE 15. Hormone Replacement Therapy MARKET FOR Parenteral, BY REGION, 2020-2028 (USD Million)

TABLE 16. Hormone Replacement Therapy MARKET FOR Others, BY REGION, 2020-2028 (USD Million)

TABLE 17. Hormone Replacement Therapy MARKET, BY REGION, 2020-2028 (USD Million)

TABLE 18. NORTH AMERICA Hormone Replacement Therapy MARKET, BY COUNTRY, 2020-2028 (USD Million)

TABLE 19. NORTH AMERICA Hormone Replacement Therapy MARKET, By Therapy Type, 2020-2028 (USD Million)

TABLE 20. NORTH AMERICA Hormone Replacement Therapy MARKET, By Indication, 2020-2028 (USD Million)

TABLE 21. NORTH AMERICA Hormone Replacement Therapy MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 (USD Million)

TABLE 22. EUROPE Hormone Replacement Therapy MARKET, BY COUNTRY, 2020-2028 (USD Million)

TABLE 23. EUROPE Hormone Replacement Therapy MARKET, By Therapy Type, 2020-2028 (USD Million)

TABLE 24. EUROPE Hormone Replacement Therapy MARKET, By Indication, 2020-2028 (USD Million)

TABLE 25. EUROPE Hormone Replacement Therapy MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 (USD Million)

TABLE 26. ASIA-PACIFIC Hormone Replacement Therapy MARKET, BY COUNTRY, 2020-2028 (USD Million)

TABLE 27. ASIA-PACIFIC Hormone Replacement Therapy MARKET, By Therapy Type, 2020-2028 (USD Million)

TABLE 28. ASIA-PACIFIC Hormone Replacement Therapy MARKET, By Indication, 2020-2028 (USD Million)

TABLE 29. ASIA-PACIFIC Hormone Replacement Therapy MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 (USD Million)

TABLE 30. LAMEA Hormone Replacement Therapy MARKET, BY COUNTRY, 2020-2028 (USD Million)

TABLE 31. LAMEA Hormone Replacement Therapy MARKET, By Therapy Type, 2020-2028 (USD Million)

TABLE 32. LAMEA Hormone Replacement Therapy MARKET, By Indication, 2020-2028 (USD Million)

TABLE 33. LAMEA Hormone Replacement Therapy MARKET, BY ROUTE OF ADMINISTRATION, 2020-2028 (USD Million)

TABLE 34. Abbott Laboratories: COMPANY SNAPSHOT

TABLE 35. Abbott Laboratories: OPERATING SEGMENTS

TABLE 36. Bayer Ag: COMPANY SNAPSHOT

TABLE 37. Bayer Ag: OPERATING SEGMENTS

TABLE 38. Eli Lily And Company: COMPANY SNAPSHOT

TABLE 39. Eli Lily And Company: OPERATING SEGMENTS

TABLE 40. Hoffmann-La Roche Ltd. (Genentech, Inc.): COMPANY SNAPSHOT

TABLE 41. Hoffmann-La Roche Ltd. (Genentech, Inc.): OPERATING SEGMENTS

TABLE 42. Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.): COMPANY SNAPSHOT

TABLE 43. Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.): OPERATING SEGMENTS

TABLE 44. Merck Kgaa: COMPANY SNAPSHOT

TABLE 45. Merck Kgaa: OPERATING SEGMENTS

TABLE 46. Mylan N.V. (Viatris Inc.): COMPANY SNAPSHOT

TABLE 47. Mylan N.V. (Viatris Inc.): OPERATING SEGMENTS

TABLE 48. Novartis International Ag: COMPANY SNAPSHOT

TABLE 49. Novartis International Ag: OPERATING SEGMENTS

TABLE 50. Novo Nordisk A/S: COMPANY SNAPSHOT

TABLE 51. Novo Nordisk A/S: OPERATING SEGMENTS

TABLE 52. Pfizer Inc: COMPANY SNAPSHOT

TABLE 53. Pfizer Inc: OPERATING SEGMENTS

 

List of Figures (21 Figures)

Figure 1 Hormone Replacement Therapy Market: Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries: Hormone Replacement Therapy Market

Figure 4 Research Methodology: Hypothesis Building

Figure 5 Hormone Replacement Therapy Market: Product-Based Estimation

Figure 6 Top 10 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2020

Figure 8 Import Data for Hormone Replacement Therapy, By Country, 2016–2020 (USD Thousand)

Figure 9 Export Data for Hormone Replacement Therapy, By Country, 2016–2020 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11 Hormone Replacement Therapy Market, By Indication, 2019 vs. 2025 (USD Million)

Figure 12 Hormone Replacement Therapy Market Share, By Route Of Administration, 2019 vs. 2025 (USD Million)

Figure 13 Hormone Replacement Therapy Market Share, By Therapy Type, 2019 vs. 2025 (USD Million)

Figure 14 Geographical Snapshot of the Hormone Replacement Therapy Market

Figure 15 Estrogen Hormone Replacement Therapy to Witness Higher CAGR in Hormone Replacement Therapy Market for Therapy Type Segment during Forecast Period.

Figure 16 Oral to Witness Higher CAGR in Hormone Replacement Therapy Market for Route Of Administration Segment during Forecast Period.

Figure 17 Menopause to Witness Higher CAGR in Hormone Replacement Therapy Market for Indication Segment during Forecast Period.

Figure 18 North America Accounted for the Largest Share of the Hormone Replacement Therapy Market, By Regional Basis, in 2019

Figure 19 Hormone Replacement Therapy Market: Drivers, Restraints, Opportunities, and Challenges

Figure 20 North America: Hormone Replacement Therapy Market Snapshot

Figure 21 Asia Pacific: Hormone Replacement Therapy Market Snapshot

Figure 22 Vendor Dive: Evaluation Overview